GILEAD SCIENCES, INC. (GILD) vs PFIZER INC (PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | GILD | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $29.44B | $62.58B |
| Revenue growth (YoY) | ▲ 2.4% | ▼ 1.6% |
| Net income | $8.51B | $7.77B |
| Gross margin | 78.8% | 74.3% |
| Diluted EPS | $6.78 | $1.36 |
| Insider net (6 mo) | +366.3K sh • 23 sells • 0 buys | +109.6K sh • 2 sells • 3 buys |
| Institutional owners | 61 | 56 |
| Institutional value held | $102.07B | $64.11B |
| Next earnings (est.) | Around Feb 9, 2027 | Feb 2, 2027 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About GILEAD SCIENCES, INC. (GILD)
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19 and cancer. Read more →
About PFIZER INC (PFE)
Pfizer Inc. is a research-based global biopharmaceutical company, incorporated in Delaware in 1942. Read more →
Source: SEC EDGAR.